BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16371368)

  • 21. Shp-2 specifically regulates several tyrosine-phosphorylated proteins in brain-derived neurotrophic factor signaling in cultured cerebral cortical neurons.
    Araki T; Yamada M; Ohnishi H; Sano S; Uetsuki T; Hatanaka H
    J Neurochem; 2000 Feb; 74(2):659-68. PubMed ID: 10646517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine phosphatase SHP-2 regulates IL-1 signaling in fibroblasts through focal adhesions.
    Herrera Abreu MT; Wang Q; Vachon E; Suzuki T; Chow CW; Wang Y; Hong O; Villar J; McCulloch CA; Downey GP
    J Cell Physiol; 2006 Apr; 207(1):132-43. PubMed ID: 16250012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of SHP-2 in fibroblast growth factor receptor-mediated suppression of myogenesis in C2C12 myoblasts.
    Kontaridis MI; Liu X; Zhang L; Bennett AM
    Mol Cell Biol; 2002 Jun; 22(11):3875-91. PubMed ID: 11997521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3'-kinase, and Grb2.
    Gadina M; Sudarshan C; O'Shea JJ
    J Immunol; 1999 Feb; 162(4):2081-6. PubMed ID: 9973481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SHP-2 phosphatase regulates DNA damage-induced apoptosis and G2/M arrest in catalytically dependent and independent manners, respectively.
    Yuan L; Yu WM; Xu M; Qu CK
    J Biol Chem; 2005 Dec; 280(52):42701-6. PubMed ID: 16260787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor.
    Ward AC; Oomen SP; Smith L; Gits J; van Leeuwen D; Soede-Bobok AA; Erpelinck-Verschueren CA; Yi T; Touw IP
    Leukemia; 2000 Jul; 14(7):1284-91. PubMed ID: 10914554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling.
    Kim SO; Jiang J; Yi W; Feng GS; Frank SJ
    J Biol Chem; 1998 Jan; 273(4):2344-54. PubMed ID: 9442080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells.
    Tang H; Zhao ZJ; Huang XY; Landon EJ; Inagami T
    J Biol Chem; 1999 Apr; 274(18):12401-7. PubMed ID: 10212213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells.
    Doan T; Farmer P; Cooney T; Ali MS
    Cell Signal; 2004 Mar; 16(3):301-11. PubMed ID: 14687660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.
    Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F
    Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis.
    Ivins Zito C; Kontaridis MI; Fornaro M; Feng GS; Bennett AM
    J Cell Physiol; 2004 May; 199(2):227-36. PubMed ID: 15040005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The adaptor function of SHP-2 downstream of the prolactin receptor is required for the recruitment of p29, a substrate of SHP-2.
    Minoo P; Chughtai N; Campiglio M; Stein-Gerlach M; Lebrun JJ; Ullrich A; Ali S
    Cell Signal; 2003 Mar; 15(3):319-26. PubMed ID: 12531430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses.
    Zhu QS; Robinson LJ; Roginskaya V; Corey SJ
    Blood; 2004 May; 103(9):3305-12. PubMed ID: 14656892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction.
    Jiao H; Yang W; Berrada K; Tabrizi M; Shultz L; Yi T
    Exp Hematol; 1997 Jul; 25(7):592-600. PubMed ID: 9216734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the protein tyrosine phosphatase SHP-1 in Ras-mediated activation of the mitogen-activated protein kinase pathway.
    Krautwald S; Büscher D; Kummer V; Buder S; Baccarini M
    Mol Cell Biol; 1996 Nov; 16(11):5955-63. PubMed ID: 8887625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docking protein Gab2 is phosphorylated by ZAP-70 and negatively regulates T cell receptor signaling by recruitment of inhibitory molecules.
    Yamasaki S; Nishida K; Hibi M; Sakuma M; Shiina R; Takeuchi A; Ohnishi H; Hirano T; Saito T
    J Biol Chem; 2001 Nov; 276(48):45175-83. PubMed ID: 11572860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt.
    Hakak Y; Hsu YS; Martin GS
    Oncogene; 2000 Jun; 19(28):3164-71. PubMed ID: 10918571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.